Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,275,197
-
Share change
-
+5,485,310
-
Total reported value
-
$72,383,175
-
Put/Call ratio
-
292%
-
Price per share
-
$3.11
-
Number of holders
-
96
-
Value change
-
+$17,113,382
-
Number of buys
-
45
-
Number of sells
-
40
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q1 2024
As of 31 Mar 2024,
Humacyte, Inc. - COM (HUMA) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,275,197 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, AIGH Capital Management LLC, Sio Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Monashee Investment Management LLC, Prescott General Partners LLC, NORTHERN TRUST CORP, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.